卡森國際(00496.HK)擬5606.91萬元出售海寧市斜橋鎮一幅地塊
格隆匯6月18日丨卡森國際(00496.HK)發佈公告,2025年6月18日,公司的全資附屬公司海寧恆森訂立物業轉讓協議,據此,海寧恆森同意出售,而華豐(即海寧市斜橋鎮華豐股份經濟合作社,爲華豐村集體所有制企業)同意購買總金額爲人民幣5606.91萬元的該地塊(包括其上建築物、裝置及設備)。
該地塊包括位於浙江省海寧市斜橋鎮建設路5號的一幅地塊,總佔地面積爲2.67萬平方米(連同其上建築物,總建築面積約爲1.84萬平方米)。該地塊連同其上建築物已獲批準作工業用途,並由海寧恆森用作工廠。於本公告日期,該地塊配套有若幹設備及裝置,主要包括電氣設備、設施及圍欄,均由海寧恆森擁有。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.